TAHIR KHWAJA: Open Payments
NPI 1881804938 · NORTH BRUNSWICK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$374 in 14 payments from 6 companies in 2025. Trend: 2023 $710 · 2024 $612 · 2025 $374
Food & beverage: $374
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $115 |
| Teva Pharmaceuticals USA, Inc. | 2 | $85 |
| Otsuka America Pharmaceutical, Inc. | 4 | $81 |
| Axsome Therapeutics, Inc. | 2 | $53 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $23 |
| Janssen Pharmaceuticals, Inc | 1 | $18 |
Products named: TRINTELLIX, UZEDY, REXULTI, Auvelity, CAPLYTA, SPRAVATO.
Industry payments across NJ — which companies pay providers there.
